Drug
Choriogonadotropin Alfa
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Product Packaging Quantity Issue | 83 | 68.2 | 70.7 | signal |
| 2 | Poor Quality Product Administered | 39 | 34.1 | 34.7 | signal |
| 3 | Ascites | 90 | 27.3 | 28.4 | signal |
| 4 | Ovarian Cyst | 21 | 18.6 | 18.8 | signal |
| 5 | Abortion Spontaneous | 73 | 16.2 | 16.7 | signal |
| 6 | Product Availability Issue | 35 | 13.9 | 14.1 | signal |
| 7 | Abdominal Pain Lower | 37 | 13.0 | 13.2 | signal |
| 8 | Abortion Induced | 13 | 12.3 | 12.4 | signal |
| 9 | Circumstance Or Information Capable Of Leading To Medication Error | 43 | 11.4 | 11.6 | signal |
| 10 | Incorrect Route Of Product Administration | 21 | 11.1 | 11.2 | signal |
| 11 | Drug Level Decreased | 12 | 10.5 | 10.5 | signal |
| 12 | No Adverse Event | 208 | 10.5 | 11.4 | signal |
| 13 | Inappropriate Schedule Of Drug Administration | 83 | 10.3 | 10.6 | signal |
| 14 | Product Dose Omission | 74 | 10.0 | 10.3 | signal |
| 15 | Pelvic Pain | 20 | 9.8 | 9.9 | signal |
| 16 | Caesarean Section | 12 | 9.1 | 9.1 | signal |
| 17 | Abdominal Distension | 100 | 8.6 | 8.9 | signal |
| 18 | Pleural Effusion | 53 | 7.8 | 7.9 | signal |
| 19 | Drug Exposure During Pregnancy | 29 | 7.5 | 7.6 | signal |
| 20 | Product Packaging Issue | 7 | 6.7 | 6.7 | signal |
| 21 | Pregnancy | 15 | 6.6 | 6.6 | signal |
| 22 | Generalised Tonic-clonic Seizure | 12 | 6.5 | 6.6 | signal |
| 23 | Hyperthyroidism | 9 | 5.5 | 5.6 | signal |
| 24 | Maternal Exposure During Pregnancy | 53 | 5.4 | 5.5 | signal |
| 25 | Needle Issue | 17 | 5.3 | 5.3 | signal |
| 26 | Product Quality Issue | 80 | 5.3 | 5.4 | signal |
| 27 | Premature Baby | 17 | 5.0 | 5.0 | signal |
| 28 | Product Physical Issue | 11 | 4.9 | 4.9 | signal |
| 29 | Incorrect Product Storage | 7 | 4.7 | 4.7 | signal |
| 30 | Hepatic Cytolysis | 6 | 4.4 | 4.4 | signal |
| 31 | Vaginal Haemorrhage | 20 | 4.2 | 4.2 | signal |
| 32 | Hunger | 6 | 4.0 | 4.0 | signal |
| 33 | Product Prescribing Issue | 9 | 3.9 | 4.0 | signal |
| 34 | Circulatory Collapse | 7 | 3.6 | 3.7 | signal |
| 35 | Vaginal Discharge | 4 | 3.5 | 3.6 | signal |
| 36 | Injury Associated With Device | 8 | 3.5 | 3.6 | signal |
| 37 | Product Dose Omission Issue | 110 | 3.4 | 3.6 | signal |
| 38 | Product Preparation Error | 8 | 3.4 | 3.4 | signal |
| 39 | Premature Delivery | 6 | 3.3 | 3.3 | signal |
| 40 | Injection Site Urticaria | 9 | 3.3 | 3.3 | signal |
| 41 | Product Storage Error | 30 | 3.1 | 3.1 | signal |
| 42 | Injection Site Irritation | 4 | 2.8 | 2.8 | no signal |
| 43 | Foetal Exposure During Pregnancy | 25 | 2.7 | 2.8 | signal |
| 44 | Adverse Reaction | 4 | 2.7 | 2.7 | no signal |
| 45 | Injection Site Reaction | 20 | 2.6 | 2.6 | signal |
| 46 | Peritonitis | 6 | 2.6 | 2.6 | signal |
| 47 | Metrorrhagia | 5 | 2.6 | 2.6 | no signal |
| 48 | Cardiovascular Disorder | 7 | 2.4 | 2.4 | signal |
| 49 | Injection Site Mass | 10 | 2.4 | 2.4 | signal |
| 50 | Injection Site Pruritus | 18 | 2.4 | 2.4 | signal |
| 51 | Exposure During Pregnancy | 16 | 2.3 | 2.3 | signal |
| 52 | Mood Swings | 8 | 2.2 | 2.2 | signal |
| 53 | Libido Decreased | 3 | 2.2 | 2.2 | no signal |
| 54 | Exposure Via Skin Contact | 5 | 2.0 | 2.0 | no signal |
| 55 | Injection Site Pain | 62 | 1.8 | 1.8 | no signal |
| 56 | Injection Site Rash | 6 | 1.8 | 1.8 | no signal |
| 57 | Injection Site Warmth | 4 | 1.7 | 1.7 | no signal |
| 58 | Drug Dose Omission | 32 | 1.7 | 1.7 | no signal |
| 59 | Injection Site Bruising | 12 | 1.4 | 1.4 | no signal |
| 60 | Injection Site Erythema | 18 | 1.3 | 1.3 | no signal |
| 61 | Injection Site Swelling | 11 | 1.3 | 1.3 | no signal |
| 62 | Incorrect Route Of Drug Administration | 5 | 1.2 | 1.2 | no signal |
| 63 | Drug Effective For Unapproved Indication | 4 | 1.2 | 1.2 | no signal |
| 64 | Dermatitis Atopic | 5 | 0.9 | 0.9 | no signal |
| 65 | Accidental Exposure To Product | 9 | 0.8 | 0.8 | no signal |
| 66 | Injection Site Haemorrhage | 7 | 0.8 | 0.8 | no signal |